NY Times today has a great story on how the European Union, fed up with high drug prices, raided a bunch of big-name pharmaceutical companies and published some of the documents from their investigation.
“I suppose we have all had conversations around ‘how we can block generic manufacturers.'”
“We identify options to obtain or acquire patents for the sole purpose of limiting the freedom of operation of our competitors.”
These aren’t new tactics. The Wall Street Journal did a huge expose about this several years ago. But what’s interesting to me is that Europe, which many of us believed did not experience the same high drug prices we do here, is also feeling the burden and they’re mad about it.